These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 17325858)
21. Interleukin-10 inhibits the in vitro proliferation of human activated leukemic CD5+ B-cells. Tangye SG; Weston KM; Raison RL Leuk Lymphoma; 1998 Sep; 31(1-2):121-30. PubMed ID: 9720722 [TBL] [Abstract][Full Text] [Related]
22. Human interleukin 4 down-regulates the surface expression of CD5 on normal and leukemic B cells. Defrance T; Vanbervliet B; Durand I; Banchereau J Eur J Immunol; 1989 Feb; 19(2):293-9. PubMed ID: 2467815 [TBL] [Abstract][Full Text] [Related]
23. Tracing CLL-biased stereotyped immunoglobulin gene rearrangements in normal B cell subsets using a high-throughput immunogenetic approach. Colombo M; Bagnara D; Reverberi D; Matis S; Cardillo M; Massara R; Mastracci L; Ravetti JL; Agnelli L; Neri A; Mazzocco M; Squillario M; Mazzarello AN; Cutrona G; Agathangelidis A; Stamatopoulos K; Ferrarini M; Fais F Mol Med; 2020 Mar; 26(1):25. PubMed ID: 32156260 [TBL] [Abstract][Full Text] [Related]
24. IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells. Coscia M; Pantaleoni F; Riganti C; Vitale C; Rigoni M; Peola S; Castella B; Foglietta M; Griggio V; Drandi D; Ladetto M; Bosia A; Boccadoro M; Massaia M Leukemia; 2011 May; 25(5):828-37. PubMed ID: 21372840 [TBL] [Abstract][Full Text] [Related]
25. Fludarabine-induced apoptosis in CD19+/CD5+B-CLL cells is a direct and nurse-like-cell independent effect. Martinez-Lostao L; Briones J; Martinez-Gallo M; Forné I; Sierra J; Rodriguez-Sanchez JL; Juarez C Leuk Lymphoma; 2004 Nov; 45(11):2307-14. PubMed ID: 15512822 [TBL] [Abstract][Full Text] [Related]
26. Overexpression of TOSO in CLL is triggered by B-cell receptor signaling and associated with progressive disease. Pallasch CP; Schulz A; Kutsch N; Schwamb J; Hagist S; Kashkar H; Ultsch A; Wickenhauser C; Hallek M; Wendtner CM Blood; 2008 Nov; 112(10):4213-9. PubMed ID: 18708628 [TBL] [Abstract][Full Text] [Related]
27. CD5 is A potential selecting ligand for B-cell surface immunoglobulin: a possible role in maintenance and selective expansion of normal and malignant B cells. Pospisil R; Silverman GJ; Marti GE; Aruffo A; Bowen MA; Mage RG Leuk Lymphoma; 2000 Jan; 36(3-4):353-65. PubMed ID: 10674908 [TBL] [Abstract][Full Text] [Related]
28. Malignant B cell CD5 membrane phenotype and B cell colony growth in vivo and in vitro in patients with B-chronic lymphocytic leukemia: analysis with clinical parameters. Hings I; Kay NE; Ranheim E; Seroogy C; Parson RE Leuk Lymphoma; 1993 Dec; 12(1-2):59-67. PubMed ID: 7512855 [TBL] [Abstract][Full Text] [Related]
29. CD5-induced apoptosis of B cells in some patients with chronic lymphocytic leukemia. Pers JO; Berthou C; Porakishvili N; Burdjanadze M; Le Calvez G; Abgrall JF; Lydyard PM; Youinou P; Jamin C Leukemia; 2002 Jan; 16(1):44-52. PubMed ID: 11840262 [TBL] [Abstract][Full Text] [Related]
30. The tyrosine kinase Syk regulates the survival of chronic lymphocytic leukemia B cells through PKCdelta and proteasome-dependent regulation of Mcl-1 expression. Baudot AD; Jeandel PY; Mouska X; Maurer U; Tartare-Deckert S; Raynaud SD; Cassuto JP; Ticchioni M; Deckert M Oncogene; 2009 Sep; 28(37):3261-73. PubMed ID: 19581935 [TBL] [Abstract][Full Text] [Related]